Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Tafenoquine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,132Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    60 Degrees Pharma Expands Tafenoquine Clinical Trial for Babesiosis
    60 Degrees Pharma Expands Tafenoquine Clinical Trial for Babesiosis

    11 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/11/2995432/0/en/60-Degrees-Pharmaceuticals-Expands-Tafenoquine-Clinical-Trial-for-Babesiosis-to-Brigham-and-Women-s-Hospital.html

    GLOBENEWSWIRE
    11 Dec 2024
    Share Share
    60 Degrees Pharma Plans Arakoda® Pilot Before US Launch Expansion
    60 Degrees Pharma Plans Arakoda® Pilot Before US Launch Expansion

    03 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/03/2957754/0/en/60-Degrees-Pharmaceuticals-Inc-Announces-ARAKODA-Promotional-Pilot-in-Advance-of-Expanded-U-S-Launch.html

    GLOBENEWSWIRE
    03 Oct 2024
    Share Share
    60 Degrees Pharma Closes $4M Private Placement At-Market Under Nasdaq
    60 Degrees Pharma Closes $4M Private Placement At-Market Under Nasdaq

    06 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/06/2942158/0/en/60-Degrees-Pharmaceuticals-Inc-Announces-Closing-of-4-Million-Private-Placement-Priced-At-the-Market-Under-Nasdaq-Rules.html

    GLOBENEWSWIRE
    06 Sep 2024
    Share Share
    60 Degrees Pharmaceuticals Announces $4M Private Placement
    60 Degrees Pharmaceuticals Announces $4M Private Placement

    04 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/04/2940442/0/en/60-Degrees-Pharmaceuticals-Inc-Announces-4-Million-Private-Placement-Priced-At-the-Market-Under-Nasdaq-Rules.html

    GLOBENEWSWIRE
    04 Sep 2024
    Share Share
    60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results
    60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results

    14 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/14/2930260/0/en/60-Degrees-Pharmaceuticals-Announces-Second-Quarter-2024-Results.html

    GLOBENEWSWIRE
    14 Aug 2024
    Share Share
    60 Degrees Pharma Supports UK's SJ733 Study With ARAKODA NDA Access
    60 Degrees Pharma Supports UK's SJ733 Study With ARAKODA NDA Access

    12 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/12/2928485/0/en/60-Degrees-Pharma-Provides-University-of-Kentucky-with-Right-of-Reference-to-ARAKODA-NDA-in-Support-of-SJ733-Phase-IIb-Study.html

    GLOBENEWSWIRE
    12 Aug 2024
    Share Share